CDA Technology is a
Game Changer.
ANPAC BIO’S CDA (CANCER DIFFERENTIATION ANALYSIS) IS A REVOLUTIONARY TECHNOLOGY

LEARN MORE

Results Speak.
10

CANCER TYPES

70%
To
90%
30K +

CONFIRMED TESTS

A Respected Team
Team_1
Dr. Chris Yu
CO-FOUNDER/ CHIEF EXECUTIVE OFFICER
Dr. Chris Yu attended medical school before changing his studies to Physics and earning his Ph.D. from Pennsylvania State University. He is a successful executive, innovative engineer, and pioneering inventor.
FULL BIO
Team_2
Dr. Herbert Yu
CO-FOUNDER/ CHIEF SCIENCE OFFICER
Dr. Herbert Yu is an M.D, with a Ph.D. in Clinical Biochemistry from University of Toronto. He is a highly acclaimed research director and professor in epidemiology and cancer research at Yale University and University Hawaii.
FULL BIO
Team_3
Drisha Leggitt
VICE PRESIDENT, BUSINESS DEVELOPMENT
Ms. Leggitt is an internationally recognized marketing and PR professional who has helped lead Fortune 500 technology companies. As a Stage 4 cancer survivor herself, she is passionate about early cancer detection.
FULL BIO
Meet the People Who Are Changing the Game